Profusa, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PFSA research report →
Price Chart
About the company
Profusa, Inc. , a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
- CEO
- Jack E. Stover
- IPO
- 2025
- Employees
- 2
- HQ
- Berkeley, CA, US
Get TickerSpark's AI analysis on PFSA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.83M
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.43
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 148.25%
- ROIC
- 242.59%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-13,223,000
- Net Income
- $-35,823,000-288.1%
- EPS
- $-107.01+70.0%
- OCF Growth
- -686.4%
- FCF Growth
- -686.8%
- 52W High
- $3000.00
- 52W Low
- $1.58
- 50D MA
- $3.92
- 200D MA
- $161.76
- Beta
- 0.50
- RSI (14)
- 42
- Avg Volume
- 2.72M
No earnings-call transcripts are available for PFSA yet.
- Free Float
- 97.6%
- Shares Outstanding
- 605.65K
- Float Shares
- 1.08M
of shares held by institutions
9 13F filers
Buy/sell ratio 1.25. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 422.57K | 0 |
| Hrt Financial LP | 170.95K | ▲ 170.95K |
| Stonex Group Inc. | 16.88K | ▲ 16.88K |
| Geode Capital Management, LLC | 16.42K | ▼ 14.30K |
| Vanguard Capital Management LLC | 3.94K | 0 |
| Tower Research Capital LLC (Trc) | 3.76K | ▲ 1.97K |
| Ifp Advisors, Inc | 3.00K | ▲ 3.00K |
| Morgan Stanley | 1.60K | 0 |
| Fmr LLC | 500 | ▲ 487 |
Held by 5 ETFs
Biggest fund positions in PFSA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 21, 26 | Knechtel Fred S. | other | 54,323 |
| Aug 21, 26 | Knechtel Fred S. | other | 301,991 |
| Aug 21, 26 | STOVER JACK E | other | 32,018 |
| Aug 21, 26 | STOVER JACK E | other | 301,991 |
| Aug 12, 26 | Knechtel Fred S. | other | 301,991 |
| Aug 12, 26 | Knechtel Fred S. | other | 0 |
| Aug 12, 26 | STOVER JACK E | other | 301,991 |
| Aug 12, 26 | STOVER JACK E | other | 0 |
| Aug 17, 26 | HRT FINANCIAL LP | sell | 18,395 |
| Aug 14, 26 | HRT FINANCIAL LP | sell | 3,163 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PFSA coverage
Recent articles, reports, and earnings notes.
No research on PFSA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PFSA report →Head to Head Review: OraSure Technologies (NASDAQ:OSUR) and Profusa (NASDAQ:PFSA)
defenseworld.net · Sep 25
Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech
benzinga.com · Sep 24
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
globenewswire.com · Sep 24
Profusa, Inc. Receives Nasdaq Compliance Determination
globenewswire.com · Sep 15
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
globenewswire.com · Aug 31
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
globenewswire.com · Aug 20
Profusa Announces 1-for-4 Reverse Stock Split
globenewswire.com · Aug 13
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
globenewswire.com · Jul 31
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.